307 related articles for article (PubMed ID: 19882979)
1. [Clinical position of sitafloxacin in outpatient chemotherapy. (discussion)].
Niki Y; Aoki N; Suzuki K; Matsumoto T
Jpn J Antibiot; 2009 Jun; 62(3):179-93. PubMed ID: 19882979
[No Abstract] [Full Text] [Related]
2. [Pharmacological properties and clinical efficacy of garenoxacin mesilate hydrate (Geninax Tablet 200 mg), a quinolone antimicrobial].
Tsuda H
Nihon Yakurigaku Zasshi; 2008 Aug; 132(2):111-8. PubMed ID: 18689961
[No Abstract] [Full Text] [Related]
3. [Quinolone antibacterials--oral preparation].
Niki Y
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():348-51. PubMed ID: 17455644
[No Abstract] [Full Text] [Related]
4. [Profile of garenoxacin as respiratory quinolones (discussion)].
Yamaguchi K
Jpn J Antibiot; 2008 Oct; 61(5):289-302. PubMed ID: 19260349
[No Abstract] [Full Text] [Related]
5. Will fluoroquinolones ever be recommended for common infections in children?
Schaad UB
Pediatr Infect Dis J; 2007 Oct; 26(10):865-7. PubMed ID: 17901790
[No Abstract] [Full Text] [Related]
6. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
Tiengrim S; Phiboonbanakit D; Thunyaharn S; Tantisiriwat W; Santiwatanakul S; Susaengrat W; Srisurat N; Malithong A; Srisangchan P; Thamlikitkul V
J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524
[TBL] [Abstract][Full Text] [Related]
7. Sitafloxacin: in bacterial infections.
Keating GM
Drugs; 2011 Apr; 71(6):731-44. PubMed ID: 21504249
[TBL] [Abstract][Full Text] [Related]
8. The newer fluoroquinolones.
Bolon MK
Infect Dis Clin North Am; 2009 Dec; 23(4):1027-51, x. PubMed ID: 19909896
[TBL] [Abstract][Full Text] [Related]
9. [Significant role of penem antibiotics: focused on faropenem (discussion)].
Saito A; Moritono S; Arata J; Saito A
Jpn J Antibiot; 1997 Jul; 50(7):579-90. PubMed ID: 9743904
[No Abstract] [Full Text] [Related]
10. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections.
Blondeau JM; Tillotson G
Int J Antimicrob Agents; 2008 Apr; 31(4):299-306. PubMed ID: 18276120
[TBL] [Abstract][Full Text] [Related]
11. [Study on the safety and efficacy of sitafloxacin--results of the use-results survey].
Matsumoto T; Uchino K; Yamaguchi H; Yoshida S; Takahashi M; Kodama H; Hamajima S; Yonemochi R; Fujita S; Takita A; Yamanouchi N; Suzuki T; Shiozawa T; Yamaguchi F
Jpn J Antibiot; 2011 Oct; 64(5):319-37. PubMed ID: 22428215
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
[No Abstract] [Full Text] [Related]
13. [Antibiotic therapy for patients with respiratory tract infection].
Kasahara K; Mikasa K
Nihon Naika Gakkai Zasshi; 2006 Nov; 95(11):2220-4. PubMed ID: 17168396
[No Abstract] [Full Text] [Related]
14. [Use of bacampicillin in the treatment of infections at diverse localizations].
Giani M; Forte A; Canale MP
Clin Ter; 1988 Sep; 126(5):345-51. PubMed ID: 2973964
[No Abstract] [Full Text] [Related]
15. Fluoroquinolones: then and now.
Pallo-Zimmerman LM; Byron JK; Graves TK
Compend Contin Educ Vet; 2010 Jul; 32(7):E1-9; quiz E9. PubMed ID: 20957609
[TBL] [Abstract][Full Text] [Related]
16. [Prediction on the efficacy of fluoroquinolones for anaerobic infections using Monte Carlo simulation].
Mikamo H; Tanaka K; Watanabe K
Jpn J Antibiot; 2007 Dec; 60(6):335-43. PubMed ID: 18447205
[TBL] [Abstract][Full Text] [Related]
17. Sitafloxacin hydrate for bacterial infections.
Anderson DL
Drugs Today (Barc); 2008 Jul; 44(7):489-501. PubMed ID: 18806900
[TBL] [Abstract][Full Text] [Related]
18. Alternatives to fluoroquinolones.
Med Lett Drugs Ther; 2016 Jun; 58(1496):75-6. PubMed ID: 27249097
[No Abstract] [Full Text] [Related]
19. Fluoroquinolones for urinary tract infection and within-household spread of resistant Enterobacteriaceae: the smoking gun.
Trautner BW
Clin Microbiol Infect; 2018 Sep; 24(9):929-930. PubMed ID: 29649605
[No Abstract] [Full Text] [Related]
20. FDA and the safe and appropriate antibiotic use of fluoroquinolones.
Tillotson GS
Lancet Infect Dis; 2016 Mar; 16(3):e11-2. PubMed ID: 26973315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
